Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Other Non-Current Liabilities (2016 - 2025)

Dexcom (DXCM) has disclosed Other Non-Current Liabilities for 16 consecutive years, with $147.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Non-Current Liabilities changed N/A to $147.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $147.4 million, a N/A change, with the full-year FY2024 number at $147.9 million, up 17.75% from a year prior.
  • Other Non-Current Liabilities was $147.4 million for Q3 2025 at Dexcom, roughly flat from $147.9 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $147.9 million in Q4 2024 to a low of $97.1 million in Q1 2022.
  • A 5-year average of $124.0 million and a median of $128.3 million in 2022 define the central range for Other Non-Current Liabilities.
  • Biggest YoY gain for Other Non-Current Liabilities was 33.77% in 2023; the steepest drop was 2.1% in 2023.
  • Dexcom's Other Non-Current Liabilities stood at $98.5 million in 2021, then skyrocketed by 30.25% to $128.3 million in 2022, then decreased by 2.1% to $125.6 million in 2023, then increased by 17.75% to $147.9 million in 2024, then decreased by 0.34% to $147.4 million in 2025.
  • Per Business Quant, the three most recent readings for DXCM's Other Non-Current Liabilities are $147.4 million (Q3 2025), $147.9 million (Q4 2024), and $129.4 million (Q1 2024).